A Study to Compare Sitavig (Acyclovir) Buccal Tablet With a Placebo in the Treatment of Herpes Labialis in Participants Whose Immune System Works Normally
Condition: Recurrent Herpes Labialis Interventions: Drug: Acyclovir 50mg buccal tablet, BAYM008894/UI1614773; Drug: Placebo Sponsor: Bayer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 28, 2021 Category: Research Source Type: clinical trials
Pharmacokinetic Properties of 200 and 400 mg Acyclovir Tablet in Indonesia Healthy Subject
Condition: Drug Use Interventions: Drug: Acyclovir 200 MG; Drug: Acyclovir 400 MG; Drug: Zovirax 200 MG Tablet; Drug: Zovirax 400 MG Tablet Sponsors: PT. Kimia Farma (Persero) Tbk; PT Pharma Metric Labs Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 3, 2021 Category: Research Source Type: clinical trials